They additionally proved that CD8+ T cells showed considerably lower cytotoxicity than B2M knockout tumor cells, indicating that B2M could mediate tumor cell escape from ICI therapy through MHC class I expression (115). This evidence concerns the gene CD8A and neoplasm.